Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Magnesium Sulfate for POCD Prevention
NCT06702488Phase 1Recruiting
- Sponsor
- Fayoum University
- Start
- Nov 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine in Post-operative cognitive dysfunction (POCD) (2 arms), sponsored by Fayoum University. Primary endpoint: Incidence of Post Operative Cognitive Dysfunction. Started Nov 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT06702488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06702488.